(Q42558853)

2 November 2017

title

Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism (English)

1 reference

2 November 2017

J L Finch

1

1 reference

2 November 2017

A J Brown

2

1 reference

2 November 2017

N Kubodera

3

1 reference

2 November 2017

Y Nishii

4

1 reference

2 November 2017

E Slatopolsky

5

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 March 1993

1 reference

2 November 2017

1 reference

2 November 2017

volume

43

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

561-566

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1993.83

2 November 2017

exact match

0 references

cites work

Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Oral calcitriol and calcium: efficient therapy for uremic hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Early dietary phosphorus restriction and calcium supplementation in the prevention of renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Hyperparathyroidism and 1,25-Dihydroxyvitamin D Deficiency in Mild, Moderate, and Severe Renal Failure*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

How Important Is Phosphate in the Pathogenesis of Renal Osteodystrophy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

On the mechanisms for the selective action of vitamin D analogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Protein-binding properties of 22-oxa-1 alpha,25-dihydroxyvitamin D3, a synthetic analogue of 1 alpha,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

1,25‐Dihydroxyvitamin D3 analog structure‐function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.83

7 January 2021

Identifiers

DOI

10.1038/KI.1993.83

1 reference

2 November 2017

1 reference